Answers are grounded in this paper and cite their sources.
Aim: To study the anticancer activity of isolated compounds from root of Aralia racemosa L and whole plant of Argyreia pilosa Wight & Arn by SRB assay method on Ishikawa human Endometrial Adenocarcinoma and SCC-29B human oral cancer cell lines.Materials and methods: Anticancer activity of isolated constituents of Aralia racemosa L and Argyreia pilosa Wight & Arn. was performed on SCC-29B and Ishikawa cancer cell lines by the Advanced Centre for Treatment Research and Education in Cancer (ACTREC) Mumbai, India.Cell line had been developed within RPMI 1640 medium that contains 10% fetal bovine serum and 2mM L-glutamine with the help of SRB assay along with the absorbance had been recorded on an Elisa plate reader at a wavelength of 540 nm with 690nm.Results: Isolated constituents particularly caffeic acid showed LC50, TGI and GI50 activity at >80, 69.7 and <10µg/ ml on Ishikawa and >80µg/ ml of GI50 activity on SCC-29B cell lines; Ursolic acid showed TGI and GI50 activity at 37.2 and <10µg/ ml on Ishikawa and 60.2, <10 and <10µg/ml of LC50, TGI and GI50 activity on SCC-29B cell lines respectively.Conclusion: Ursolic acid from Aralia racemosa L and Caffeic acid from Argyreia pilosa Wight & Arn has been showed anticancer activity SCC-29B and Ishikawa cancer cell line has been showed potent anticancer activity.
No takes yet. Share an insight, caveat, or question.
DSNBK et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: